ArticleNeuroImage. Clinical2026
Fronto-striatal neurometabolite signatures of impulsivity in early abstinence from methamphetamine.
Article in NeuroImage. Clinical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMethamphetamine use is associated with neurometabolite alterations and increased impulsivity, but relationships between neurometabolites and specific impulsivity dimensions remain unclear, particularly during early abstinence when relapse risk is high and recovery is dynamic.
methodsWe studied 20 recently abstinent individuals and 21 age-matched controls. Single-voxel MRS was acquired in the bilateral dorsolateral prefrontal cortex (DLPFC), medial prefrontal cortex (mPFC), anterior cingulate cortex (ACC), and caudate (CAUD) to quantify N-acetylaspartate (NAA), myo-inositol (mI), choline compounds (GPC + PCh), and glutamate and glutamine (Glu + Gln) concentrations relative to total creatine (Cr + PCr). Group differences in neurometabolite ratios were tested with linear mixed-effects models, and impulsivity was tested across six Barratt Impulsiveness Scale (BIS-11) first-order factors with mixed-design ANCOVA. Regressions assessed whether neurometabolite concentrations predicted impulsivity and whether relationships differed between groups, adjusting for education, depression, anxiety, and stress.
resultsRecently abstinent individuals scored higher on three BIS-11 factors (Motor, Self-Control, Cognitive Complexity). MRS showed elevated mI/Cr + PCr and GPC + PCh/Cr + PCr in the CAUD and increased GPC + PCh/Cr + PCr in the mPFC, while NAA and Glu + Gln ratios did not differ. Motor impulsivity was predicted only by higher stress. Lower self-control was associated with higher CAUD mI/Cr + PCr in age-matched controls but not in recently abstinent individuals. Cognitive Complexity was predicted by group, with no neurometabolite effects.
conclusionsFronto-striatal glial dysregulation contributes to impulsivity in methamphetamine use disorder. Preservation of NAA despite glial changes suggests a distinct neurochemical profile of early abstinence. Stress and glial dysfunction, potentially involving neuroinflammatory processes, may jointly drive impulsivity, highlighting intervention targets. Integrating MRS with behavioral measures provides insight into relapse vulnerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.